{
    "id": "nclex_ngn_trend_mission_500_109",
    "questionType": "trend",
    "caseId": "cardiogenic_shock_500",
    "title": "Cardiogenic Shock with Arrhythmia",
    "body": "A 68-year-old client with a history of hypertension and hyperlipidemia was admitted to the cardiac intensive care unit (CICU) 4 hours ago following an emergent percutaneous coronary intervention (PCI) for a large anterior wall ST-elevation myocardial infarction (STEMI). The client developed cardiogenic shock post-procedure. The client reports inconsistent access to primary care due to transportation issues, leading to poorly managed chronic conditions. The nurse is preparing to implement a new provider's order.",
    "tabs": [
        {
            "id": "nurses_notes",
            "title": "Nurses' Notes",
            "type": "text",
            "content": [
                {
                    "time": "0800",
                    "note": "Client transferred to CICU post-PCI. Alert and oriented x3, responds to questions. Skin is cool and pale. Bilateral breath sounds with fine crackles in the bases. S1S2 audible, S3 gallop noted. Peripheral pulses +1 radial and dorsalis pedis. Urine output via indwelling catheter is 15 mL/hr. Norepinephrine and Dobutamine infusions initiated and titrated per protocol to maintain MAP >65 mmHg."
                },
                {
                    "time": "1000",
                    "note": "Client appears more anxious. Complains of mild shortness of breath. Crackles now audible in lower half of lung fields bilaterally. Skin remains cool. MAP has been maintained between 68-72 mmHg. Urine output 20 mL over the past hour. Provider notified of respiratory status change."
                },
                {
                    "time": "1200",
                    "note": "Client is restless and agitated. BP remains low despite increased vasopressor support. Heart rate is persistently tachycardic. Monitor shows frequent multifocal premature ventricular contractions (PVCs). One brief, 6-second run of a wide-complex tachycardia was observed, which resolved spontaneously. SpO2 is difficult to maintain above 92%. Provider is aware of rhythm changes."
                }
            ]
        },
        {
            "id": "vital_signs",
            "title": "Vital Signs",
            "type": "table",
            "data": {
                "headers": [
                    "Time",
                    "HR (bpm)",
                    "BP (mmHg)",
                    "MAP (mmHg)",
                    "SpO2 (%)",
                    "RR (breaths/min)",
                    "CVP (mmHg)"
                ],
                "rows": [
                    [
                        "0800",
                        "105",
                        "82/56",
                        "65",
                        "94% on 4L NC",
                        "22",
                        "16"
                    ],
                    [
                        "1000",
                        "110",
                        "88/62",
                        "71",
                        "93% on 4L NC",
                        "24",
                        "18"
                    ],
                    [
                        "1200",
                        "122",
                        "84/60",
                        "68",
                        "92% on 6L NC",
                        "26",
                        "19"
                    ]
                ]
            }
        },
        {
            "id": "diagnostic_results",
            "title": "Diagnostic Results",
            "type": "text",
            "content": [
                {
                    "type": "Laboratory Results",
                    "time": "0800",
                    "results": [
                        "Troponin-I: 25.2 ng/mL (Reference: <0.04 ng/mL)",
                        "Lactate: 4.8 mmol/L (Reference: 0.5-2.2 mmol/L)",
                        "Potassium (K+): 3.6 mEq/L (Reference: 3.5-5.0 mEq/L)",
                        "BUN: 34 mg/dL (Reference: 7-20 mg/dL)",
                        "Creatinine: 1.8 mg/dL (Reference: 0.6-1.2 mg/dL)"
                    ]
                },
                {
                    "type": "ECG Interpretation",
                    "time": "1215",
                    "results": [
                        "Rhythm: Sinus Tachycardia at 122 bpm.",
                        "Findings: Frequent multifocal premature ventricular contractions (PVCs). A 6-beat run of non-sustained ventricular tachycardia (NSVT) is noted. Q-waves in anterior leads consistent with recent infarct."
                    ]
                }
            ]
        },
        {
            "id": "mar",
            "title": "MAR",
            "type": "text",
            "content": [
                {
                    "type": "Continuous Infusions",
                    "medications": [
                        "Norepinephrine 8 mg in 250 mL D5W, infusing at 10 mcg/min.",
                        "Dobutamine 500 mg in 250 mL D5W, infusing at 5 mcg/kg/min."
                    ]
                },
                {
                    "type": "PRN Medications",
                    "medications": [
                        "Amiodarone 150 mg IV push over 10 minutes, for symptomatic ventricular arrhythmias."
                    ]
                },
                {
                    "type": "New Orders",
                    "time": "1230",
                    "medications": [
                        "Increase Dobutamine infusion to 7.5 mcg/kg/min."
                    ]
                }
            ]
        }
    ],
    "stem": "The nurse reviews the client's electronic health record. Which of the following actions should the nurse take in response to the new order at 1230? Select all that apply.",
    "scoring": {
        "type": "multiSelect",
        "correct": [
            "option_1",
            "option_3",
            "option_4"
        ]
    },
    "options": [
        {
            "id": "option_1",
            "label": "Withhold the dobutamine infusion increase."
        },
        {
            "id": "option_2",
            "label": "Increase the norepinephrine infusion to 15 mcg/min."
        },
        {
            "id": "option_5",
            "label": "Administer a 250 mL bolus of 0.9% sodium chloride."
        },
        {
            "id": "option_4",
            "label": "Prepare to administer the PRN amiodarone."
        },
        {
            "id": "option_3",
            "label": "Contact the provider to question the dobutamine order and report the latest ECG findings."
        },
        {
            "id": "option_6",
            "label": "Request an order for an arterial blood gas (ABG)."
        }
    ],
    "answerBreakdown": {
        "option_1": {
            "correct": true,
            "rationale": "This is a critical safety action. The client's trend data shows increasing heart rate and worsening ventricular irritability (frequent PVCs, NSVT). Dobutamine, a beta-1 agonist, increases myocardial oxygen demand and is known to be pro-arrhythmic. Increasing the infusion is contraindicated as it will likely exacerbate the life-threatening arrhythmia. The nurse must recognize this contraindication and 'stop' the action."
        },
        "option_2": {
            "correct": false,
            "rationale": "While the client's MAP is low (68 mmHg), the immediate life-threatening problem is ventricular tachycardia, not hypotension. Increasing norepinephrine might improve blood pressure, but it does not address the underlying electrical instability and can also increase myocardial oxygen demand. The priority is to manage the arrhythmia first."
        },
        "option_3": {
            "correct": true,
            "rationale": "This is a crucial communication and advocacy step. After withholding the potentially harmful medication, the nurse must immediately contact the provider. The nurse should use SBAR (Situation, Background, Assessment, Recommendation) to report the new ECG showing NSVT, the client's restlessness, and question the order to increase the arrhythmogenic agent."
        },
        "option_4": {
            "correct": true,
            "rationale": "The client is experiencing symptomatic ventricular irritability (restlessness, potential hemodynamic compromise from NSVT), which is a life-threatening condition. The MAR contains a PRN order for amiodarone for this exact indication. The nurse should anticipate and prepare to administer this antiarrhythmic medication to stabilize the client's cardiac rhythm, likely after confirming with the provider during the communication in option 3."
        },
        "option_5": {
            "correct": false,
            "rationale": "This action is dangerous and contraindicated. The client is in cardiogenic shock, characterized by pump failure and fluid volume overload. The CVP is elevated (19 mmHg), and there are signs of pulmonary edema (crackles, dyspnea). Administering a fluid bolus would increase preload on an already failing ventricle, worsening pulmonary congestion and respiratory failure."
        },
        "option_6": {
            "correct": false,
            "rationale": "While an ABG would provide useful information about the client's acid-base and oxygenation status, it is not the priority action. The immediate life threat is the ventricular arrhythmia. The nurse's first actions must be to prevent further harm (withhold dobutamine) and treat the existing electrical instability (notify provider, prepare amiodarone). Assessment can occur after stabilizing the immediate crisis."
        }
    },
    "references": [
        {
            "source": "American Heart Association (AHA) Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.",
            "type": "Clinical Practice Guideline"
        },
        {
            "source": "Harding, M. M., Kwong, J., Roberts, D., Hagler, D., & Reinisch, C. (2023). Lewis's medical-surgical nursing: Assessment and management of clinical problems (12th ed.). Elsevier.",
            "type": "Textbook"
        }
    ]
}